Response Biomedical Corp (RBM) financial statements (2020 and earlier)

Company profile

Business Address 1781 - 75TH AVENUE W.
VANCOUVER, BC V6P6P2
State of Incorp. BC
Fiscal Year End December 31
SIC 8734 - Testing Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3332
Cash and cash equivalents3332
Receivables1111
Inventory, net of allowances, customer advances and progress billings2222
Inventory2222
Deferred costs000 
Prepaid expense and other current assets0
Other undisclosed current assets0000
Total current assets:5666
Noncurrent Assets
Property, plant and equipment6678
Prepaid expense000
Restricted cash and investments1111
Deferred costs00  
Prepaid expense and other noncurrent assets0
Total noncurrent assets:7789
TOTAL ASSETS:12141414
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3432
Accounts payable3432
Accrued liabilities00  
Debt1100
Derivative instruments and hedges, liabilities0154
Deferred revenue and credits1100
Other undisclosed current liabilities0000
Total current liabilities:6796
Noncurrent Liabilities
Long-term debt and lease obligation, including:5566
Long-term debt, excluding current maturities0166
Other undisclosed long-term debt and lease obligation44  
Liabilities, other than long-term debt 000
Deferred revenue and credits 000
Other undisclosed noncurrent liabilities1212
Total noncurrent liabilities:6778
Total liabilities:13151614
Stockholders' equity
Stockholders' equity attributable to parent(1)(1)(1)0
Common stock10410410299
Additional paid in capital15151513
Accumulated deficit(120)(120)(118)(112)
Total stockholders' equity:(1)(1)(1)0
TOTAL LIABILITIES AND EQUITY:12141414

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
1511124
Cost of revenue
(Cost of Goods and Services Sold)
(7)(7)(7)(8)
Other undisclosed gross profit 008
Gross profit:8454
Operating expenses(8)(9)(8)(8)
Other operating expense, net  (3)(1)
Operating income (loss):0(5)(6)(5)
Nonoperating income (expense)(0)720
Investment income, nonoperating1420
Foreign currency transaction loss, before tax(0)(0)(0)(0)
Other nonoperating income (expense)(0)30 
Interest and debt expense(1)(1)(1)(1)
Income (loss) from continuing operations before income taxes:(1)1(5)(6)
Income tax expense (0)(0) 
Net income (loss):(1)1(5)(6)
Other undisclosed net income (loss) attributable to parent1(3)(1)1
Net loss available to common stockholders, diluted:(0)(2)(6)(5)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(1)1(5)(6)
Comprehensive income (loss), net of tax, attributable to parent:(1)1(5)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: